HS10296, a novel irreversible EGFR TKI, attenuates epithelial-mesenchymal transition facilitated by M2-polarizedtumor-associated macrophages in Non-Small Cell Lung Cancer | Zendy

AI Assistant Blog Pricing

HS10296, a novel irreversible EGFR TKI, attenuates epithelial-mesenchymal transition facilitated by M2-polarizedtumor-associated macrophages in Non-Small Cell Lung Cancer

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.